Option chain shows key data for Venus Concept's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Venus Concept.

Venus Concept (NASDAQ:VERO) Stock, Option Chain

Venus Concept

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Stock Market Graph,Trading,Analysis,Investment,Financial,,Stock,Exchange,Financial

Exclusives

Trading Ideas

$SOL

AAPL

AMZN

AREB

BULL

CLSK

FMTO

ICCT

JNVR

MARA

NAOV

NMAX

NVDA

PLTR

RSLS

SMCI

TSLA

VERO

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

EXCLUSIVE: April&#39;s 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Apple, Palantir, Nvidia Stocks Rank?

Movimiento de acciones

Pre-Market Outlook

Markets

ALTI

ARGX

ASNS

BOOM

BWMX

CERT

CMRE

INNV

MAZE

MSPR

NEXA

ONVO

RXRX

SLSR

STSS

YCBD

Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket

Crude Oil and Petroleum Trade in the Crosshairs

Equities

News

Eurozone

Commodities

Intraday Update

KROS

KTTA

MRIN

Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump

Venus Concept Inc

VERONI BRANDS CORP by Veroni Brands Corporation

Verona Pharma plc - American Depositary Shares

Verona Pharma PLC

Press Releases

Venus Concept Announces Senior Management Changes

Venus Concept Announces 1-for-11 Reverse Stock Split

Venus Concept to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025

Earnings

Venus Concept Announces Fourth Quarter and Fiscal Year 2024 Financial Results

Financing

Venus Concept Announces $11 million Debt-to-Equity Exchange Transaction

Venus Concept to Release First Quarter of Fiscal Year 2025 Financial Results on May 15, 2025

Venus Concept Announces $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Venus Concept Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Venus Concept Raises a Total of Approximately $2.7 Million in Gross Proceeds from Previously Announced Registered Direct Offerings of Common Stock

Aethlon Medical

Autonomix Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

Bluejay Diagnostics

Biomerica

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

GlucoTrack

HeartSciences

Helius Medical Technologies, Inc. - Class A Common Stock

Helius Medical Tech

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

INVO Fertility

Know Labs

LogicMark

NanoVibronix

ENDRA Life Sciences

Nuwellis

Predictive Oncology

ReShape Lifesciences, Inc. - Common Stock

Reshape Lifesciences

SINTX Technologies

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems

Tenon Medical

Catheter Precision

Ladenburg Thalmann

Comments

Venus Concept

Venus Concept (VERO) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell